An Unusual Presentation of Craniofacial Fibrous Dysplasia: A Case Report, Review and Update on Management by Guru, Kanishka Navin et al.
 Guru KN et al. American Journal of Oral and Maxillofacial Surgery 2014, 2:15-22  
Ivy Union Publishing | http: //www.ivyunion.org August 19, 2015 | Volume 2 | Issue 1 
Page 1 of 8 
 
 
An Unusual Presentation of Craniofacial 
Fibrous Dysplasia: A Case Report, Review 
and Update on Management 
 
Kanishka. N Guru
1*
, Rajeev Borle
2
, and Rashmi. K Guru
3
 
 
1
 Department of Oral and Maxillofacial Surgeon , Chirayu Medical College and Hospital Bhopal 
(Madhya Pradesh), India  
2
 Department of Oral and Maxillofacial Surgeon, DMIMS University, 
Sawangi (Meghe) Wardha Maharashtra, India  
Opthalmologist 
3 
G.S.M Hospital Bhopal (Madhya Pradesh), India 
 
‘ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: Monostotic Fibrous Dysplasia;Maxilla; G Protein; geneGNAS; Subtotal Maxillectomy 
Academic Editor: Xiaoning Peng, PhD, Department of Internal Medicine, Hunan Normal University School of 
Medicine 
Received: June 18, 2015 Accepted: July 29, 2015 Published: August 19, 2015 
Competing Interests: The authors have declared that no competing interests exist. 
Copyright: 2015 Guru KN et al. This is an open-access article distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original author and source are credited. 
*Correspondence to: Kanishka. N Guru, Department of Oral and Maxillofacial Surgeon , Chirayu Medical 
College and Hospital Bhopal (Madhya Pradesh), India
Email: kanishkanavinguru@gmail.com 
 
 
 
Abstract: 
Fibrous dysplasia (FD) is a non-malignant condition caused by post-zygotic, activating mutations of the GNAS gene that 
results in inhibition of the differentiation and proliferation of bone-forming stromal cells and leads to the replacement of 
normal bone and marrow by fibrous tissue and woven bone. The phenotype is variable and may be isolated to a single 
skeletal site or multiple sites and sometimes is associated with extra skeletal manifestations in the skin and/or endocrine 
organs (McCune-Albright syndrome). The clinical behavior and progression of FD may also vary, thereby making the 
management of this condition difficult with few established clinical guidelines. This case report provides a 
clinically-focused comprehensive description of craniofacial FD, its natural progression, the components of the diagnostic 
evaluation and the multi-disciplinary management. 
 
American Journal of Oral and Maxillofacial Surgery 
http://ivyunion.org/index.php/maxillofacial/ 
 
Research Article 
 
 Guru KN et al. American Journal of Oral and Maxillofacial Surgery 2014, 2:15-22  
Ivy Union Publishing | http: //www.ivyunion.org August 19, 2015 | Volume 2 | Issue 1 
Page 2 of 8 
Introduction  
Fibrous dysplasia (FD) is a non-malignant condition in which normal bone and marrow are replaced by 
fibrous tissue and haphazardly distributed woven bone [1, 2]. Patients may exhibit involvement of one 
bone (monostotic FD; MFD), multiple bones (polyostotic FD; PFD) or they may have 
McCune-Albright syndrome (MAS), which has been classically defined by the triad of PFD, 
café-au-lait skin macules and endocrinopathies, including among others, precocious puberty [3]. FD is 
caused by somatic activating mutations in the α subunit of the stimulatory G protein encoded by the 
gene GNAS [4, 5]. MFD is reported to be the most common manifestation of the disease, in some 
references it is estimated to occur four times more often than PFD [6]. However, in other series PFD is 
reported to be more common than MFD [7, 8]. While the prevalence of MFD is probably greater than 
PFD, in none of the studies that define the relative prevalence of MFD versus PFD have the subject’s 
under-gone thorough skeletal and/or endocrine screening to determine the full extent of the skeletal 
and/or endocrine involvement. The most common locations are the cranio-facial bones, proximal femur, 
and rib [2, 8, 9]. In MFD, the zygomatic-maxillary complex is reported to be the region most 
commonly involved [10]. In the less prevalent PFD and MAS, the craniofacial region is involved in 90% 
of the cases and the anterior cranial base is involved in over 95% of cases [11]. Depending on the type 
and location of FD, the signs and symptoms vary and include facial deformity and asymmetry, vision 
changes, hearing impairment, nasal congestion and/or obstruction, pain, paresthesia, and malocclusion. 
Many patients are asymptomatic and the diagnosis is made when a family member, friend or health 
care provider who has not seen the patient for a period of time notices asymmetry, or there is an 
incidental abnormality noted on dental or panoramic x-rays or on a head and neck computed tomogram 
(CT).Uncommonly, in young children and pre-pubertal adolescents, the lesions may demonstrate rapid 
growth, cortical bone expansion and displacement of adjacent structures such as the eye and the teeth. 
In some patients, rapid growth is associated with other pathological lesions such as aneurysmal bone 
cysts (ABC) or mucoceles [11, 12] more rarely with malignant transformation. Malignant change to 
osteosarcoma or other forms of sarcoma has been reported to occur in less than 1% of cases of FD [11, 
13].In addition, in the NIH Screening and Natural History Study of Fibrous Dysplasia (SNHFD, 
protocol 98-D-0145) has documented persistent active disease and pain into adulthood in some patients. 
Based on >25 years of observation at the NIH, it appears that MFD, does not progress to PFD and 
neither progress to MAS [14].  
Case Report  
A 10-year-old boy reported to our hospital with a painless, diffused, progressive swelling over right 
side of the face. As per the history given by the patient the swelling was initially of the size of a peanut 
which within the period of 6 months increased rapidly to present size .On clinical evaluation a diffused 
 Guru KN et al. American Journal of Oral and Maxillofacial Surgery 2014, 2:15-22  
Ivy Union Publishing | http: //www.ivyunion.org August 19, 2015 | Volume 2 | Issue 1 
Page 3 of 8 
swelling extending from right infraorbital margin to inferior border of the mandible (craniocaudally), 
mediolaterally from ala of the nose to tragus of right ear (Figure 1). Extra oral clinical examination 
reveals obstruction of right nostril completely. The patient was suffering from eye symptoms like 
epiphora and proptosis with no signs of diplopia, with no history of paresthesia (Figure 2). Intraoral 
examination reveals the tumor extending from right maxillary central incisor extending to the posterior 
border of maxilla; swelling is so extensive obliterating the right upper buccal vestibular region (Figure  
3). Patient medical, family and social history was unremarkable. There was no history of trauma. 
During taking an incisional biopsy the bleeding was significant and diagnosed as MFD. The patient 
was subsequently admitted to the hospital and taken for surgery under general anesthesia. The 
treatment has been planned to do the subtotal maxillectomy and ligation of the terminal branch of 
external carotid artery like (maxillary artery and superficial temporal artery and vein.) The treatment 
has been accordingly planned to resect the tumor enbloc in Toto. The Fibrous dysplasia created a 
cleavage between a healthy bone and tumor margins. By seeing the socio economic condition, the 
patient doesn’t afford the cost embolization of the terminal branches of the external carotid artery, so 
the treatment has been planned to ligate the terminal branches of the external carotid artery and enbloc 
resection of the tumor. By taking the consent of the patient considering the age of the patient and the 
present reports of CBC the hemoglobin was 8 gm. /dl, it is decided to give extra oral incision and to 
ligate the external carotid artery in reteromandibular fossa and resection of the tumor intra orally. The 
complication has been explained to the patient like diplopia, paresthesia, facial nerve paralysis, 
hematoma, infection, facial aesthetic deformity, meningitis and consent taken. The resection of tumor 
has been done and the peripheral margins of the tumor like inferior margin of the orbit, infra temporal 
fossa, nasal cavity and its posterior extension to pharynx, nasolacrimal duct has been sent for frozen 
sections. As per the reports of frozen section the tumor is resected successfully and the peripheral 
margins are free of the lesion. During resection the Pterygoid hammulus is exposed intraoral and the 
reconstruction of the pterygoid hammulus has been done by pedicled buccal fat pad and remaining 
defect covered with spilt thickness skin graft. The defect has been packed with sterile gauze. 
Intraoperative the total blood loss was about 150ml of blood which was replaced inter and post 
operatively with 2 units of packed cell volume. As previously decided in treatment plan the intra oral 
impression has been taken and the obturator has been prepared previously. After removal of the sterile 
pack the defect has been carefully examined and the obturator is fixed with the help of Adams clasp. 
Patient responded well to surgery postoperatively without any complication as explained to patient. 
Preoperatively the Intraocular pressure of the Right eye when checked with schiotz tonometer was 
increased to 24mmhg with 5.5gmwt which after surgery decreased to 20mmhg due to resection of the 
tumor. Tumor was extending into the ethymoid sinus invading the cribriform plate of ethymoidwhich 
resulted in CSF leak when the tumor was resected. Thecribriform plate of theethymoid has been 
invaded by the tumor and the reconstruction of cribriform plate has been done by the chin 
graft .Postoperatively after 5 days the CSF rhinorrhea is stopped.  Ryles tube feeding was started to 
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the patient postoperatively to avoid infection. After review of 3 months, 6 months there was no 
complication present. As per the socio economic condition of the patient it is not possible to 
reconstruct the defect with micro vascular graft. So the patient has been reviewed after 6 months 
(Figure 6) and planned for reconstruction of the floor of the orbit and maxilla. Patient had epiphora 
from Right eye and when checked for exophthalmos of Right eye with Lueddes exophthalmometer it 
showed proptosis of Right eye by 24mm as compared to Left eye. Vision in Right eye was normal 6/6. 
There were no signs of exposure keratopathy. 
Investigation 
(1) On radiological examination CT scan shows a swelling of size 29 x 50.5mm, multilocular, 
expansile, lytic lesion involving the anterior wall of the right maxillary sinus medially the 
tumor extending into the right nostril and obstructing the right nasolacrimal duct, cribriform 
plate of ethymoid superiorly the tumor was perforating the floor of the orbit, the posterior limit 
of the tumor up to infratemporal fossa. The tumor shows foci of calcification with no 
intracranial abnormality (Figure 4). 
(2) All the investigations like complete blood picture Hb-8gm./dl , serum electrolytes, blood 
grouping, prothrombin time, plasma thromboplastin time, INR, parathyroid hormone, calcium, 
phosphorus, serum alkaline phosphatase are within normal limits. 
(3) Incision biopsy performed. Histopathological examination (HPE) report suggestive of Fibrous 
dysplasia.As per histopathological report showing the aggressive monostotic fibrous dysplasia 
reveals irregular bony trabeculae with osteoblasts surrounded by interlacing bundles of 
monomorphic spindle cell, the fibroblast exhibit uniform spindle to star shaped nuclei. The 
bony trabecular assume bizarre irregular shapes likened to Chinese character (Figure 5). 
(4) Excisional biopsy confirmed the report of the incisional biopsy. 
 
 
   
Figure 1 Facial Profile 
 
Figure 2 Lateral Profile 
 
Figure 3 Intraoral Profile 
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Figure 4 Computed Tomogram showing  
extension multilocular, expansile, lytic lesion 
involving the anterior wall of the right maxillary 
sinus medially the tumor extending into the right 
nostril and obstructing the right nasolacrimal duct, 
cribriform plate of ethymoid superiorly the tumor 
was perforating the floor of the orbit, the posterior 
limit of the tumor up to infratemporal fossa. The 
tumor shows foci of calcification with no intracranial 
abnormality. 
 
 
 
  
 
Figure 5 Histopathological features suggestive of Fibrous 
DysplasiaFibroblasts within woven cancellous bone 
 
 
Figure 6 OPG showing 3 months Postoperative 
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Differential Diagnosis 
The primary Differential Diagnosis for Fibrous Dysplasia of jaw is ossifying  fibroma. Clinical, 
radiographic and microscopic features must be considered together in order to distinguish these 
processes most accurately. In general lesion diagnosed as ossifying fibroma has a thin bony shell and a 
distinct boundary seen in Radiograph. Whereas the two lesions were based only on histologic criteria. 
Fibrous dysplasia way reported to contain only woven bones without evidence of osteoblastic rimming 
of bone. The presence of mature lamellar bone was believed to be characteristic of ossifying fibroma. 
Most authorities now acknowledge that criteria are unreliable because both types of bone may be found 
in eitherlesion [15]. Sign and symptoms of fibrous dysplasia and sclerosing osteomyelitis of Garre may 
be clinically distinguishable. Radiographically both diseases may produce appearances characterized 
by region of sclerosis with or without osteolytic area with enlargement of jaw. The enlargement in 
sclerosing osteomyelitis is due to periosteal new bone formation .Where as in fibrous dysplasia it is the 
result of appositional bone formation on the outer side of cortex secondary to remodeling of the 
endosteal erosion. Histologically garre osteomyelitis is characterized by dense mass of sclerotic bone 
in fibrous marrow with chronic inflammatory cell infiltrate. Paget’s disease share some feature of 
fibrous dysplasia, but it occurs in a much older age group and typically exhibit a bilateral distribution. 
Alkaline phosphatase levelis characteristically in Paget’s disease [16]. A related disorder, cherubism, is 
manifest by expansile, multiloculated, radiolucent fibro-osseous lesions with multiple giant cells 
located bilaterally and symmetrically in the jaws. 
Outcome and Follow up 
After 6-month follow-up period, no sign of recurrence was observed. The patient continues to be on regular 
follow-up. 
Discussion 
Craniofacial FD is a genetic nonhereditary disease that has a benign course in most patients. It can 
progress beyond puberty, and there is no correlation between age and clinical course. Cranial nerve 
involvement is rare in this population. The presence of mucoceles or bone cyst may increase the risk of 
visual deterioration caused by optic nerve compression. The absence of level-1 evidence on the 
management of patients with FD makes it difficult to decide on the optimal patient management. It is 
difficult to predict which patient will progress to have a debilitating disease. Considering the risk of 
surgical injury to the ON together with the unknown course of the disease, the possibility of an adverse 
outcome must be considered seriously before operating on asymptomatic patients. The accumulated 
experience Fibrous Dysplasia 897 reported in the literature revealed in the authors’ meta-analysis 
shows no difference in the visual deterioration rate between prophylactically and therapeutically 
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decompressed nerves. The significantly lower rate of adverse visual outcome in conservatively treated 
patients suggests that performing decompression in asymptomatic patients unnecessarily puts the ON 
at risk. Moreover, the prevalence of visual deterioration during follow-up is rare, even in patients with 
MAS who usually exhibit a more aggressive course of disease. In conclusion, published data and the 
authors’ meta-analysis suggest that symptomatic patients with ON involvement can safely be managed 
by an endonasal surgery directed toward partial decompression of the optic canal. Early diagnosis and 
treatment was necessary in this case to avoid the further complications of the tumor like   intracranial 
involvement, cranial nerve damage, orbital involvement, optic nerve damage, skull base involvement, 
oropharyngeal obstruction and enigmatic complications. So early diagnosis and aggressive surgical 
intervention is necessary in this type of cases. The ligation of terminal branches of external carotid 
artery was done to prevent the further blood loss. Genetic studies  involving mutation of GNAS genes 
is therefore necessary to prevent this debilitating condition affecting early age group from occurring 
and early diagnosis and treatment techniques should be researched through genetic study. The 
incidence of malignant transformation of FD is 0.4% [16, 17]. 
Learning Points 
1) Aggressively screen for and manage endocrinopathies (particularly growth hormone excess). 
2) Active disease (rapid growth, new onset of pain or paresthesia, visual or hearing changes) 
warrants an immediate surgical referral and evaluation. 
3) A bone biopsy should be obtained if there is any doubt about the diagnosis. If the lesion is in a site 
that cannot be biopsied due to unacceptable risks, history, clinical examination and radiographic 
diagnosis may be adequate for diagnosis. 
4) What pharmacologic or molecular therapies may reverse the effects of the abnormal gene products 
in FD? 
5) Does the detectability of a Gs mutation in a fibro-osseous lesion predict clinical behavior? 
6) Is mutation testing a necessary component of FD evaluation and gene therapy necessary? 
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